RegMed XB has a growth model with an undefined range. The pioneering nature of the research makes this necessary; the determination of the partners makes it possible. In the first five years, we started with the four Moonshots, but over time new research projects can start. The number of partners and the budget will grow further.
RegMed XB aims to be the leading European institute of regenerative medicine and will be a worldwide renowned valorization institute in RM. Research into complex diseases will never be finished and does not stop at the border. It is our dream to align the initiatives worldwide into the relevant disease areas. This way each country will do what they do best but we ensure a coordinated effort to cure chronic disease. In the future, partnerships with other very large and successful regenerative medicine hot spots such as in Boston and California are also obvious.